Toscana virus infections in northern Italy: laboratory and clinical evaluation.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 22448679)

Published in Vector Borne Zoonotic Dis on March 26, 2012

Authors

Caterina Vocale1, Michele Bartoletti, Giada Rossini, Pierluigi Macini, Maria Grazia Pascucci, Fernanda Mori, Andrea Tampieri, Tiziano Lenzi, Michele Pavoni, Claudia Giorgi, Paolo Gaibani, Francesca Cavrini, Anna Maria Pierro, Maria Paola Landini, Pierluigi Viale, Vittorio Sambri

Author Affiliations

1: Department of Haematology and Oncology L. and A. Seragnoli, Section of Microbiology, St. Orsola University Hospital, University of Bologna, Bologna, Italy.

Articles by these authors

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann Intern Med (2007) 5.62

Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis (2012) 4.62

Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. Arthritis Rheum (2008) 2.45

Imported Chikungunya Infection, Italy. Emerg Infect Dis (2007) 2.08

Susceptibility of Helicobacter pylori to metronidazole. Am J Gastroenterol (2003) 1.98

Chikungunya virus in North-Eastern Italy: a seroprevalence survey. Am J Trop Med Hyg (2010) 1.94

In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother (2013) 1.83

A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med (2013) 1.74

Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics (2005) 1.69

Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antivir Ther (2004) 1.65

2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg (2013) 1.65

Single-reaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses. PLoS Negl Trop Dis (2013) 1.57

New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol (2007) 1.57

Isolation of usutu virus in Germany. Am J Trop Med Hyg (2011) 1.55

The Chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus (2008) 1.53

Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR. J Infect (2009) 1.50

Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin Pharmacokinet (2007) 1.47

Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharmacokinet (2005) 1.45

Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies. Clin Infect Dis (2012) 1.45

Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert Rev Anti Infect Ther (2013) 1.36

Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol (2004) 1.34

Chikungunya: an emerging and spreading arthropod-borne viral disease. J Infect Dev Ctries (2009) 1.33

WSES consensus conference: Guidelines for first-line management of intra-abdominal infections. World J Emerg Surg (2011) 1.29

West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system. Blood Transfus (2008) 1.29

Evaluation of LIAISON Treponema Screen, a novel recombinant antigen-based chemiluminescence immunoassay for laboratory diagnosis of syphilis. Clin Diagn Lab Immunol (2005) 1.26

Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res (2003) 1.25

Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study. World J Emerg Surg (2012) 1.24

The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project. Haematologica (2011) 1.23

Remodelling of the nuclear lamina during human cytomegalovirus infection: role of the viral proteins pUL50 and pUL53. J Gen Virol (2008) 1.23

Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae (2011) 1.19

Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients. Antimicrob Agents Chemother (2009) 1.17

Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. J Antimicrob Chemother (2012) 1.16

Conventional and molecular techniques for the early diagnosis of bacteraemia. Int J Antimicrob Agents (2010) 1.16

Anion binding by protonated forms of the tripodal ligand tren. Inorg Chem (2009) 1.15

HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation. Biochem Biophys Res Commun (2010) 1.12

Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis. Scand J Infect Dis (2006) 1.12

Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis (2011) 1.12

Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis. Antimicrob Agents Chemother (2010) 1.11

Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter? Crit Care (2009) 1.11

Molecular detection of Treponema denticola and Porphyromonas gingivalis in carotid and aortic atheromatous plaques by FISH: report of two cases. J Med Microbiol (2005) 1.11

Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient. Clin Infect Dis (2006) 1.09

Human infection with highly pathogenic A(H7N7) avian influenza virus, Italy, 2013. Emerg Infect Dis (2014) 1.09

DNA interaction with Ru(II) and Ru(II)/Cu(II) complexes containing azamacrocycle and dppz residues. A thermodynamic, kinetic and theoretical study. Dalton Trans (2010) 1.09

DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice. Vaccine (2003) 1.09

Mosquito, bird and human surveillance of West Nile and Usutu viruses in Emilia-Romagna Region (Italy) in 2010. PLoS One (2012) 1.08

Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages. Clin Pharmacokinet (2004) 1.07

Carboxy and Phosphate Esters Cleavage with Mono- and Dinuclear Zinc(II) Macrocyclic Complexes in Aqueous Solution. Crystal Structure of [Zn(2)L1(&mgr;-PP)(2)(MeOH)(2)](ClO(4))(2) (L1 = [30]aneN(6)O(4), PP(-) = Diphenyl Phosphate). Inorg Chem (1997) 1.06

Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy. Medicine (Baltimore) (2014) 1.05

Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections. Int J Infect Dis (2010) 1.05

Immunological evaluation and cellular location analysis of the TprI antigen of Treponema pallidum subsp. pallidum. Infect Immun (2005) 1.05

Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay. J Clin Virol (2011) 1.04

Comparative evaluation of three different ELISA methods for the diagnosis of early culture-confirmed Lyme disease in Italy. J Med Microbiol (2005) 1.04

Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. J Leukoc Biol (2004) 1.04

Congenital cytomegalovirus infection in twin pregnancies: viral load in the amniotic fluid and pregnancy outcome. Pediatrics (2003) 1.04

The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida. Virulence (2012) 1.03

Surveillance of hospital-acquired infections: a model for settings with resource constraints. Am J Infect Control (2006) 1.03

Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia. Am J Hematol (2006) 1.03

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database. J Antimicrob Chemother (2013) 1.02

Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings. Vaccine (2005) 1.02

The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? Clin Infect Dis (2006) 1.02

Laboratory diagnosis of late-onset sepsis in newborns by multiplex real-time PCR. J Med Microbiol (2009) 1.02

Detection of Usutu virus within a West Nile virus surveillance program in Northern Italy. Vector Borne Zoonotic Dis (2010) 1.01

Phylogenetic analysis of West Nile virus isolates, Italy, 2008-2009. Emerg Infect Dis (2011) 1.00

Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge. Eur Heart J (2007) 1.00

Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors. Curr HIV Res (2008) 1.00

Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. Am J Gastroenterol (2004) 1.00

False-positive transcription-mediated amplification assay detection of West Nile virus in blood from a patient with viremia caused by an Usutu virus infection. J Clin Microbiol (2010) 1.00

Plasma levels of bacterial DNA in HIV infection: the limits of quantitative polymerase chain reaction. J Infect Dis (2010) 0.99

Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose. J Antimicrob Chemother (2003) 0.98